Editorial
The early days of letrozole
The discovery and mechanism of action of letrozole
Letrozole in advanced breast cancer: the PO25 trial
ERRATUM
Letrozole in the neoadjuvant setting: the P024 trial
Letrozole in the extended adjuvant setting: MA.17
Letrozole as upfront endocrine therapy for postmenopausal women with hormone-sensitive breast cancer: BIG 1-98
A decade of letrozole: FACE
Safety of aromatase inhibitors in the adjuvant setting
The patient experience
Femara® and the future: tailoring treatment and combination therapies with Femara